Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 169.60B | 152.41B | 125.93B | 110.05B | 95.31B |
Gross Profit | 98.76B | 84.66B | 73.82B | 63.01B | 52.74B |
EBITDA | 70.41B | 63.56B | 54.25B | 46.30B | 37.39B |
Net Income | 48.45B | 43.37B | 36.74B | 32.55B | 24.92B |
Balance Sheet | |||||
Total Assets | 312.98B | 243.48B | 217.37B | 187.37B | 163.71B |
Cash, Cash Equivalents and Short-Term Investments | 166.78B | 125.19B | 102.12B | 107.26B | 71.24B |
Total Debt | 11.92B | 12.16B | 11.75B | 6.10B | 6.83B |
Total Liabilities | 86.68B | 48.40B | 56.24B | 40.89B | 42.92B |
Stockholders Equity | 226.30B | 195.08B | 161.13B | 146.47B | 120.80B |
Cash Flow | |||||
Free Cash Flow | 61.34B | 31.79B | 14.37B | 42.88B | 11.50B |
Operating Cash Flow | 67.62B | 36.92B | 21.79B | 46.95B | 14.63B |
Investing Cash Flow | -7.27B | -5.96B | -7.68B | -7.43B | -4.23B |
Financing Cash Flow | -18.73B | -15.97B | -22.48B | -9.98B | -6.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | $83.12B | 19.11 | 23.93% | 2.03% | 1.26% | 6.84% | |
76 Outperform | $12.67B | 40.17 | 22.64% | 0.76% | 5.29% | 28.32% | |
72 Outperform | $73.09B | ― | -460.30% | ― | 30.24% | 27.61% | |
70 Outperform | $38.58B | 36.16 | 16.13% | 0.49% | -0.81% | -9.28% | |
64 Neutral | $1.82B | 12.91 | -220.61% | 8.11% | 1.64% | -32.31% | |
61 Neutral | $40.70B | -0.98 | -11.97% | 3.93% | 2.03% | -69.70% | |
57 Neutral | $43.03B | ― | -114.76% | ― | 5.31% | -15.57% |